NCT03614377

Brief Summary

This prospective multicenter registry study aims to determine whether device-detected sleep-disordered breathing events are associated increased risk of cardiac arrhythmias or other cardiovascular outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

15 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 30, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 3, 2018

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

June 30, 2021

Status Verified

June 1, 2021

Enrollment Period

5.3 years

First QC Date

July 30, 2018

Last Update Submit

June 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with atrial fibrillation

    cardiac implantable electronic device-detected or clinical atrial fibrillation

    from enrollment to last follow-up (2 years)

Secondary Outcomes (2)

  • Number of participants with complications associated with atrial fibrillation

    from enrollment to last follow-up (2 years)

  • Number of participants with ventricular arrhythmia

    from enrollment to last follow-up (2 years)

Other Outcomes (1)

  • Number of participants with major adverse composite events

    from enrollment to last follow-up (2 years)

Study Arms (2)

Patients with low burden of sleep-disordered breathing

Diagnostic Test: Device interrogation

Patients with high burden of sleep-disordered breathing

Diagnostic Test: Device interrogation

Interventions

Device interrogationDIAGNOSTIC_TEST

All devices are interrogated at every follow-up, and two questionnaires are performed 2 years after enrollment.

Also known as: Berlin Questionnaire, EuroQol five dimensions questionnaire
Patients with high burden of sleep-disordered breathingPatients with low burden of sleep-disordered breathing

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent implantation of cardiac implantable electronic device (CIED) with AP scan function (Boston Scientific.Inc) are eligible for the study during the first 3±1 months after CIED implantation.

You may qualify if:

  • age ≥ 19years
  • CHA2DS2VASc score ≥ 1 in male or ≥ 2 in female

You may not qualify if:

  • CIED without atrial lead
  • persistent or permanent atrial fibrillation (AF) or flutter
  • history of catheter of surgical ablation of AF
  • valvular steno-insufficiency more than moderate degree
  • chronic obstructive pulmonary disease
  • under current treatment for sleep-disordered breathing
  • life expectancy \< 1year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Samsung Changwon Medical Center

Changwon, South Korea

Location

Chungbuk National University Hospital

Chungju, South Korea

Location

Chonnam National University Hospital

Daegu, South Korea

Location

Daegu Catholic University Medical Center

Daegu, South Korea

Location

Yeongnam University Medical Center

Daegu, South Korea

Location

Chungnam National University Hospital

Daejeon, South Korea

Location

Eulji University Hospital

Daejeon, South Korea

Location

Chonnam National University Hospital

Gwangju, South Korea

Location

Sejong General Hospital

Sejong, South Korea

Location

Asan Medical Center

Seoul, South Korea

Location

Korea University Anam Hospital

Seoul, South Korea

Location

Seoul National University Bundang Hospital

Seoul, South Korea

Location

Seoul National University Hospital

Seoul, South Korea

Location

The Catholic University of Korea, Seoul St. Mary's Hospital

Seoul, South Korea

Location

Yonsei University Health System, Severance Hospital

Seoul, South Korea

Location

Related Publications (1)

  • Gwag HB, Park Y, Lee SS, Kim JS, Park KM, On YK, Lee DI, Shin DG, Choi EK, Kang GH, Park HS, Park HW, Shim JM, Uhm JS, Kim J, Kim JH, Kang KW, Park SW, Oh YS, Cho Y, Lee YS, Park SJ. Rationale, design, and endpoints of the 'DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)' study: Prospective multicenter observational study of device-detected tachyarrhythmia and sleep-disordered breathing. Int J Cardiol. 2019 Apr 1;280:69-73. doi: 10.1016/j.ijcard.2019.01.045. Epub 2019 Jan 15.

MeSH Terms

Conditions

Sleep Wake DisordersCardiovascular Diseases

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Seung-Jung Park, PhD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2018

First Posted

August 3, 2018

Study Start

April 28, 2017

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

June 30, 2021

Record last verified: 2021-06

Locations